Serial Number
88880733
Owner
LIFE SCIENCE INSTITUTE, INC.Attorney
Danielle I. MattessichFiling Date
Apr 21, 2020
Serial #88880733 Trademark
Serial Number: 88880733 • Registration: 6741952
Trademark Classes
Owner Contact Info
2929 West Anderson Lane
Austin, TX 78757
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
April 21, 2020
Registration Date
May 31, 2022
Published for Opposition
November 2, 2021
Goods & Services
Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical preparations containing stem cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical composition containing cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction, spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD); Pharmaceutical composition containing stem cells for the treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction,spinal cord injuries, amyotrophic lateral sclerosis (ALS), interstitial cystitis, acute respiratory distress syndrome (ARDS), peripheral arterial disease (PAD) and neonatal chronic lung disease (CLD)
